| Building a law-and-political-economy framework: Beyond the twentieth-century synthesis J Britton-Purdy, DS Grewal, A Kapczynski, KS Rahman Yale lJ 129, 1784, 2019 | 544 | 2019 |
| The access to knowledge mobilization and the new politics of intellectual property A Kapczynski Yale LJ 117, 804, 2007 | 493 | 2007 |
| Addressing global health inequalities: An open licensing approach for university innovations A Kapczynski, S Chaifetz, Z Katz, Y Benkler Berkeley Tech. LJ 20, 1031, 2005 | 295 | 2005 |
| Harmonization and its discontents: a case study of TRIPS implementation in India's pharmaceutical sector A Kapczynski Calif. L. Rev. 97, 1571, 2009 | 294 | 2009 |
| The cost of price: Why and how to get beyond intellectual property internalism A Kapczynski UCLA L. Rev. 59, 970, 2011 | 235 | 2011 |
| The law of informational capitalism A Kapczynski Yale LJ 129, 1460, 2019 | 224 | 2019 |
| Access to knowledge in the age of intellectual property G Krikorian, A Kapczynski Zone Books, 2010 | 212 | 2010 |
| The continuum of excludability and the limits of patents A Kapczynski, T Syed Yale LJ 122, 1900, 2012 | 182 | 2012 |
| A prescription for excessive drug pricing: leveraging government patent use for health H Brennan, A Kapczynski, CH Monahan, Z Rizvi Yale JL & Tech. 18, 275, 2016 | 151 | 2016 |
| Polymorphs and prodrugs and salts (oh my!): an empirical analysis of “secondary” pharmaceutical patents A Kapczynski, C Park, B Sampat PLoS one 7 (12), e49470, 2012 | 131 | 2012 |
| Is Bayh-Dole good for developing countries? Lessons from the US experience AD So, BN Sampat, AK Rai, R Cook-Deegan, JH Reichman, R Weissman, ... PLoS biology 6 (10), e262, 2008 | 127 | 2008 |
| Order without intellectual property law: Open science in influenza A Kapczynski Cornell L. Rev. 102, 1539, 2016 | 109 | 2016 |
| Same-Sex Privacy and the Limits of Antidiscrimination Law A Kapczynski Yale LJ 112, 1257, 2002 | 79 | 2002 |
| Access to knowledge: a conceptual genealogy A Kapczynski Amy Kapczynski, ACCESS TO KNOWLEDGE IN THE AGE OF INTELLECTUAL PROPERTY …, 2010 | 76 | 2010 |
| Innovation sticks: the limited case for penalizing failures to innovate I Ayres, A Kapczynski U. Chi. L. Rev. 82, 1781, 2015 | 60 | 2015 |
| Patents, trade and medicines: past, present and future KC Shadlen, BN Sampat, A Kapczynski Review of International Political Economy 27 (1), 75-97, 2020 | 58 | 2020 |
| ‘Government Patent Use’: A Legal Approach To Reducing Drug Spending A Kapczynski, AS Kesselheim Health Affairs 35 (5), 791-797, 2016 | 52 | 2016 |
| The big data regulator, rebooted: Why and how the FDA can and should disclose confidential data on prescription drugs and vaccines CJ Morten, A Kapczynski Cal. L. Rev. 109, 493, 2021 | 51 | 2021 |
| Dangerous times: The FDA's role in information production, past and future A Kapczynski Minn. L. Rev. 102, 2357, 2017 | 51 | 2017 |
| The public history of trade secrets A Kapczynski UC Davis L. Rev. 55, 1367, 2021 | 48 | 2021 |
